Flucloxacillin

The Effect of Antimicrobial Therapy on the Serum Level of P-cresol in Peritoneal Dialysis Patients

Flucloxacillin as an Inducer of CYP-enzymes

Study of Daptomycin in Subjects Undergoing Surgery for Osteomyelitis Associated With an Infected Prosthetic Caused by Staphylococci

Staphylococcus Aureus Bacteremia Antibiotic Treatment Options

Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Children, Known or Suspected to be Caused by Susceptible Gram-positive Organisms, Including MRSA

Adjunctive Clindamycin for Cellulitis: C4C Trial.

Duration of ANtibiotic Therapy for CEllulitis

Penicillin for the Emergency Department Outpatient Treatment of CELLulitis

Penicillin Against Flucloxacillin Treatment Evaluation

Staphylococcus aureus Network Adaptive Platform trial (SNAP)

Early shift to oral antibiotic treatment of pyogenic vertebral osteomyelitis – a open label non-inferiority randomized nationwide study.

The DALBA-study Introduction of the antibiotic dalbavancin in orthopaedic surgery – an evaluation of: • Health economic costs • Patient-reported outcomes on quality of life • Local bone and soft tissue concentrations • Effect on the gut microbiome A randomised controlled study of dalbavancin versus standard antibiotic treatment of Gram-positive periprosthetic joint infections.

Defining Antibiotic Levels in Intensive care patients (DALI-2) protocol - A multi-national pharmacokinetic/pharmacodynamic cohort study to determine whether contemporary antibiotic dosing for critically ill patients achieves therapeutic exposures.

Study of Acupuncture and Care Interventions for the Treatment of Breast Inflammation During Breastfeeding

Comparing the Intravenous Treatment of Skin Infections in Children, Home Versus Hospital

Pharmacokinetics of Flucloxacillin Given by Continuous or Intermittent Infusion to ICU Patients